EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 12 February 2026

European pharmaceuticals key to strengthening EU competitiveness

Discover the ten actions

Without the pharmaceutical industry, the EU trade balance would shift from a €147 billion surplus to a €47 billion deficit, leaving Europe more exposed to external dependencies.

As global competition intensifies, it’s a now-or-never moment for Europe. These are the 10 actions that will enable the pharmaceutical sector to strengthen Europe’s competitiveness, growth, and security.

Digital Medicines Information gains momentum
09 February 2026

A new report from AESGP, EFPIA and Medicines for Europe provides a comprehensive overview of electronic Product Information... Read more

Events

Building trustworthy 21st century healthcare systems: Results from the OECD Patient Reported...
19 February 2026 (Online)

Join this OECD webinar, which explores the findings presented in Chapter 6 of the PaRIS flagship report, highlighting... Read more

J&J | The essentials of partnering with a pharma company
19 March 2026 (Utrecht & Virtual)

Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation... Read more

What we are reading

‘Saving Lives’: Comic book combines science & storytelling
On 05 February 2026 (Vaccines Today)

When an epidemic on a Pacific island sparks fears of a global pandemic, a heroic Belgian scientist with the help... Read more

From ambition to delivery – An urgent call for action in 2026
On 05 February 2026 (Business Europe)

In the run-up to the European elections in 2024, BusinessEurope called for a “REBOOT” in European policies, focussing... Read more

Making the manufacturing of medical products better with IHI and IMI
On 30 January 2026 (IHI)

Europe’s competitiveness and health resilience will improve thanks to strides made by IHI and IMI projects in medical... Read more

Measles in Europe: How to get back on track
On 28 January 2026 (Vaccines Today)

Measles is circulating in 25% of countries in the WHO’s 53-member European region. It has made an unwelcome return... Read more

The state of cardiovascular health in the European Union
On 15 December 2025 (OECD)

Cardiovascular disease (CVD) remains the leading cause of death and disability in the European Union, with significant... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu